As a leading company in the IVD field, Humasis is dedicated to supporting healthcare providers. As a part of the response to the COVID-19 pandemic, Humasis is continually observing SARS-CoV-2 variants.
The Humasis COVID-19 Ag Test product was confirmed to detect COVID-19 Omicron sub-variant BA.4 with the same sensitivity as wild type. We had announced that our product could detect Omicron variant B.1.1.529 with the same sensitivity as a wild type not only the Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Kappa (B.1.617.1), Epsilon (B.1.429), Eta (B.1.525), and Iota (B.1.526).
For more information, please download the Technical Bulletin on Testing the COVID-19 Omicron sub-variant BA.4 here.